Cargando…
Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities
Bone remodeling, a dynamic process in which bone formation by osteoblast is preceded by bone resorption by osteoclast, is a vital physiological process for maintaining bone mass and strength, imbalances in which could precipitate osteoporosis. Due to the unilateral mechanism of the existing bone rem...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327267/ https://www.ncbi.nlm.nih.gov/pubmed/34349644 http://dx.doi.org/10.3389/fphar.2021.670254 |
_version_ | 1783732040438382592 |
---|---|
author | Imtiyaz, Zuha Lin, Yi-Tzu Liang, Fang-Yu Chiou, Wen-Fei Lee, Mei-Hsien |
author_facet | Imtiyaz, Zuha Lin, Yi-Tzu Liang, Fang-Yu Chiou, Wen-Fei Lee, Mei-Hsien |
author_sort | Imtiyaz, Zuha |
collection | PubMed |
description | Bone remodeling, a dynamic process in which bone formation by osteoblast is preceded by bone resorption by osteoclast, is a vital physiological process for maintaining bone mass and strength, imbalances in which could precipitate osteoporosis. Due to the unilateral mechanism of the existing bone remodeling drugs, identifying compounds that could regulate the balance between osteoclast and osteoblast could improve the treatment of osteoporosis. Here, we show that compounds isolated from Wikstroemia taiwanensis modulate osteoclast and osteoblast activities. Specifically, astragalin (1) and kaempferol 3-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside (2), besides increasing mineral deposition, increased alkaline phosphatase activity (137.2% for 1 and 115.8% for 2) and ESR-α expression (112.8% for 1 and 122.5% for 2) in primary human osteoblasts. In contrast, compounds 1, 2, 3, and 5 inhibited tartrate-resistant acid phosphatase (TRAP) activity in receptor activator of nuclear factor-κB ligand-induced osteoclasts by 40.8, 17.1, 25.9, and 14.5% and also decreased the number of TRAP-positive cells by 51.6, 26.8, 20.5, and 18.6%, respectively. Our findings, therefore, showed that compounds isolated from W. taiwanensis could increase osteoblast activity while simultaneously decreasing osteoclast activity, and hence, warrant further evaluation for development as anti-osteoporosis agents. |
format | Online Article Text |
id | pubmed-8327267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83272672021-08-03 Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities Imtiyaz, Zuha Lin, Yi-Tzu Liang, Fang-Yu Chiou, Wen-Fei Lee, Mei-Hsien Front Pharmacol Pharmacology Bone remodeling, a dynamic process in which bone formation by osteoblast is preceded by bone resorption by osteoclast, is a vital physiological process for maintaining bone mass and strength, imbalances in which could precipitate osteoporosis. Due to the unilateral mechanism of the existing bone remodeling drugs, identifying compounds that could regulate the balance between osteoclast and osteoblast could improve the treatment of osteoporosis. Here, we show that compounds isolated from Wikstroemia taiwanensis modulate osteoclast and osteoblast activities. Specifically, astragalin (1) and kaempferol 3-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside (2), besides increasing mineral deposition, increased alkaline phosphatase activity (137.2% for 1 and 115.8% for 2) and ESR-α expression (112.8% for 1 and 122.5% for 2) in primary human osteoblasts. In contrast, compounds 1, 2, 3, and 5 inhibited tartrate-resistant acid phosphatase (TRAP) activity in receptor activator of nuclear factor-κB ligand-induced osteoclasts by 40.8, 17.1, 25.9, and 14.5% and also decreased the number of TRAP-positive cells by 51.6, 26.8, 20.5, and 18.6%, respectively. Our findings, therefore, showed that compounds isolated from W. taiwanensis could increase osteoblast activity while simultaneously decreasing osteoclast activity, and hence, warrant further evaluation for development as anti-osteoporosis agents. Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8327267/ /pubmed/34349644 http://dx.doi.org/10.3389/fphar.2021.670254 Text en Copyright © 2021 Imtiyaz, Lin, Liang, Chiou and Lee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Imtiyaz, Zuha Lin, Yi-Tzu Liang, Fang-Yu Chiou, Wen-Fei Lee, Mei-Hsien Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title | Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title_full | Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title_fullStr | Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title_full_unstemmed | Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title_short | Compounds Isolated from Wikstroemia taiwanensis Regulate Bone Remodeling by Modulating Osteoblast and Osteoclast Activities |
title_sort | compounds isolated from wikstroemia taiwanensis regulate bone remodeling by modulating osteoblast and osteoclast activities |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327267/ https://www.ncbi.nlm.nih.gov/pubmed/34349644 http://dx.doi.org/10.3389/fphar.2021.670254 |
work_keys_str_mv | AT imtiyazzuha compoundsisolatedfromwikstroemiataiwanensisregulateboneremodelingbymodulatingosteoblastandosteoclastactivities AT linyitzu compoundsisolatedfromwikstroemiataiwanensisregulateboneremodelingbymodulatingosteoblastandosteoclastactivities AT liangfangyu compoundsisolatedfromwikstroemiataiwanensisregulateboneremodelingbymodulatingosteoblastandosteoclastactivities AT chiouwenfei compoundsisolatedfromwikstroemiataiwanensisregulateboneremodelingbymodulatingosteoblastandosteoclastactivities AT leemeihsien compoundsisolatedfromwikstroemiataiwanensisregulateboneremodelingbymodulatingosteoblastandosteoclastactivities |